Insider Transactions Reported by 19 Insiders of Elevation Oncology, Inc.

Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 25 Dec 2024

Elevation Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Qiming U.S. Healthcare Fund II, L.P. 10%+ Owner $1.21M 29 Jun 2021
Vertex Global HC Fund II Pte. Ltd. 10%+ Owner $1.18M 29 Jun 2021
Cormorant Asset Management, LP Former 10% Owner $1.14M 29 Jun 2021
venBio Global Strategic Fund III, L.P. 10%+ Owner $972K 25 May 2022
Joseph J. Ferra Jr CHIEF EXECUTIVE OFFICER, Director $252K 16 Jun 2025
Valerie Malyvanh Jansen Chief Medical Officer $237K 15 Feb 2025
David Dornan Chief Scientific Officer $41.5K 15 Feb 2025
Tammy Furlong Chief Financial Officer $1.61K 23 Jul 2025
TIMOTHY P. CLACKSON Director $0 23 Jul 2025
R. Michael Carruthers Director 23 Jul 2025
Richard Gaster Director 24 Jun 2021
Julie M. Cherrington Director 23 Jul 2025
STEVE ELMS Director 23 Jul 2025
Aisling Capital IV, LP 10%+ Owner 16 Jun 2023
Colin Walsh Director 16 Jun 2023
Lori Hu Director 16 Jun 2023
Alan B. Sandler Director 23 Jul 2025
Shawn Leland President, CEO, Director 14 Feb 2022
Darcy Mootz Director 23 Jul 2025

Recent Insider Transactions by Companies or Individuals for Elevation Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.